Jiangsu Apon Medical Technology Co., Ltd.
爱朋医疗
Jiangsu Apon Medical Technology (SZSE ChiNext: 300753), founded in 2001 and headquartered in Rudong, Nantong, is a Chinese medical device maker focused on pain management and nasal/upper-airway care.
About
Jiangsu Apon Medical Technology (SZSE ChiNext: 300753), founded in 2001 and headquartered in Rudong, Nantong, is a Chinese medical device maker focused on pain management and nasal/upper-airway care. Through subsidiaries Apon Zhiyuan Brain Science Technology (Shanghai) and Shenzhen Pengrui Brain Science Technology, it is expanding into brain-computer interfaces, with anesthesia-depth monitoring, ADHD behavioral therapy and insomnia treatment products.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Jiangsu Apon Medical Technology Co., Ltd.
Jiangsu Apon Medical Technology (SZSE ChiNext: 300753), founded in 2001 and headquartered in Rudong, Nantong, is a Chinese medical device maker focused on pain management and nasal/upper-airway care. Through subsidiaries Apon Zhiyuan Brain Science Technology (Shanghai) and Shenzhen Pengrui Brain Science Technology, it is expanding into brain-computer interfaces, with anesthesia-depth monitoring, ADHD behavioral therapy and insomnia treatment products.
—
United States
BusinessLatest roundTotal raisedDate- Coherence Neuro
Closed-loop brain-computer interface system SOMA, using a wireless implant to decode tumor electrical signals in real time and deliver personalized electrical stimulation to treat brain tumors and other cancers
Seed · 2026-10
— - Axoft
Implantable brain-computer interfaces using biomimetic materials, with flexible neural electronics for high-resolution neural recording and stimulation
Series A · $60M · 2026-05
$60M - Neuralink
Focused on developing brain-computer interface technology
Undisclosed · $930M · 2025-06
$930M
China
BusinessLatest roundTotal raisedDate- BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M - Sisheng Technology
AI-driven ultrasound brain-computer interface and multimodal brain data platform
Seed · 2026-08
— - SiClink
Founded in December 2025, SiClink is an implantable brain-computer interface company founded by ShanghaiTech University researcher Dr. He Fei. It develops semiconductor hollow flexible neural electrodes and a proprietary saline-based stiffness-modulation minimally invasive implantation process to build high-bandwidth, low-latency, long-term stable bidirectional brain-machine interfaces, starting with visual reconstruction.
—
Europe
BusinessLatest roundTotal raisedDate- MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
— - InBrain Neuroelectronics
Graphene-based brain-computer interface technology for neurological disorders such as Parkinson's disease.
Series B · $50M · 2024-11
$50M - Neurosoft Bioelectronics
Flexible, stretchable, non-penetrating brain-computer interfaces and neural electrodes to record/stimulate brain-surface activity
Seed · $20M · 2026-05
$20M
Other / unspecified
BusinessLatest roundTotal raisedDate- 脑思科技
Brain-computer interface electrodes and neural decoding systems
Angel · $10M · 2026-05
$10M - FIZE Medical
Digital urine output monitoring and smart fluid management for critical care (FIZE kUO)
Series B · 2026-09
— - Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.